Spinal cord injury -- a focus on restoring function
September 15, 2011 By Stacy Stark in Medical research
Imagine that you are driving home from work today when you are involved in a head on collision with an SUV. Life Lion flies you to the hospital. When you awake in the Emergency Department, you notice that you cannot feel your legs. Your doctor tells you that you may not able to walk. You also eventually realize that you cannot urinate or defecate voluntarily.
This is an all too familiar scenario for many people within the United States. Motor vehicle crashes are the No. 1 cause of spinal cord injury (SCI). Approximately, 10,000 people in the U.S. will suffer a new SCI this year, and approximately 250,000 people in the U.S. are living with SCI.
The most common level of tetraplegia (paralysis with all four extremities involved) is cervical level 5. This means you cannot move your hands, wrists, and legs and your sensation stops slightly below the nipple line, with no feeling below that. The most common level of paraplegia (paralysis with legs involved) is thoracic level 12. This means you cannot move your legs and your feeling stops at your waist, with no sensation below that.
Major improvements in the pre-hospital management of patients with an acute spinal cord injury have lead to an improved neurologic prognosis for SCI patients. The most important factor in this management process is cervical spinal stabilization at the scene of injury. A standard spinal cord injury specific examination immediately after injury provides information needed to measure recovery. These repeated examinations are used to predict individual recovery.
When SCI is complete, you have no movement or feeling below the level of injury. However, many people do regain some movement and sensation after injury.
Approximately 80 percent of patients with complete injury have a chance of remaining complete at one year. Those with an initial certain incomplete injury with certain characteristics -- sensation and or movement below the level of injury -- have a variable recovery prognosis, sometimes with as high as a 90 percent chance of walking again following rehabilitation.
SCI has a long recovery. After the acute hospital stay, many patients enter acute inpatient rehabilitation during which patients still require medical care, but receive three hours of therapy every day, five days a week. This rehabilitation lasts for approximately four weeks. During this phase, the patient learns how to care for themselves, and the patient and family are educated about daily care and how to perform it, if applicable.
The rehabilitation team consists of doctors, nurses, therapists, a nutritionist, a care coordinator, a social worker and a psychologist. Ultimately, the rehabilitation teams goal is restoring function. A multidisciplinary approach focuses on a patient's medical, physical, emotional and psychological well-being. A physician called a physiatrist will lead the rehabilitation team. Physiatrists are doctors who have done their residency in the medical field of Physical Medicine and Rehabilitation, and are experts in caring for patients with acquired and congenital disabilities.
Suffering a SCI is serious, but treatment has advanced greatly. Activities based restorative therapy with functional electrical stimulation has shown promising results in restoring function to those with both complete and incomplete spinal cord injuries. Currently, there is no cure for SCI, but this may change one day through the research that is currently being done.
Stacy Stark is an assistant professor in the Department of Physical Medicine and Rehabilitation and the medical director of the Outpatient Physical Medicine and Rehabilitation Clinic and director of Education for the Department of Physical Medicine and Rehabilitation.
Provided by
Pennsylvania State University
-
Researchers use MRI to predict recovery after spinal cord injury
May 29, 2007 |
not rated yet |
0
-
Elderly spinal cord injuries increase five-fold in 30 years
Mar 19, 2007 |
not rated yet |
0
-
Northwestern first site open for spinal cord stem cell trial
Sep 22, 2010 |
not rated yet |
0
-
Intensive training post-spinal cord injury can stimulate repair in brain and spinal cord
Dec 18, 2007 |
not rated yet |
0
-
Nation's second participant enrolls in human embryonic stem cell trial
May 12, 2011 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
How can there be a term called "intestinal metaplasia" of stomach
22 hours ago
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
-
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013
-
Alcohol and acetaminophen
May 13, 2013
- More from Physics Forums - Medical Sciences
More news stories
H. pylori, smoking trends, and gastric cancer in US men
Trends in Helicobacter pylori (H. pylori) and smoking explain a significant proportion of the decline of intestinal-type noncardia gastric adenocarcinoma (NCGA) incidence in US men between 1978 and 2008, and are estimated ...
Medical research
12 hours ago |
not rated yet |
0
Common food supplement fights degenerative brain disorders
Widely available in pharmacies and health stores, phosphatidylserine is a natural food supplement produced from beef, oysters, and soy. Proven to improve cognition and slow memory loss, it's a popular treatment for older ...
Medical research
16 hours ago |
5 / 5 (3) |
0
|
Finding a family for a pair of orphan receptors in the brain
Researchers at Emory University have identified a protein that stimulates a pair of "orphan receptors" found in the brain, solving a long-standing biological puzzle and possibly leading to future treatments for neurological ...
Medical research
17 hours ago |
5 / 5 (1) |
0
|
Insight into the dazzling impact of insulin in cells
Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.
Medical research
17 hours ago |
4.6 / 5 (7) |
0
|
Do men's and women's hearts burn fuel differently?
Researchers at the University of Illinois at Chicago College of Medicine will study gender differences in how the heart uses and stores fat—its main energy source—and how changes in fat metabolism play ...
Medical research
20 hours ago |
not rated yet |
0
Study says empathy plays a key role in moral judgments
Is it permissible to harm one to save many? Those who tend to say "yes" when faced with this classic dilemma are likely to be deficient in a specific kind of empathy, according to a report published in the scientific journal ...
Phthalates: Study links chemicals widely found in plastics, processed food to elevated blood pressure in children, teens
Plastic additives known as phthalates (pronounced THAL-ates) are odorless, colorless and just about everywhere: They turn up in flooring, plastic cups, beach balls, plastic wrap, intravenous tubing and—according to the ...
If you can remember it, you can remember it wrong
(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...
B vitamins could delay dementia
(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...
New sleeping pill poised to hit US markets
An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.
Reducing caloric intake delays nerve cell loss
Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...